Pharmacists in Greenwood, IN Accepting Medicare
74 Pharmacists found. Showing 61 - 74
 Mason Leonard Hallewell, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 555 Echo Bend Blvd, Greenwood, IN 46142 Phone: 317-701-5468 |
Trent D Chappell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 Us 31 South, Greenwood, IN 46143 Phone: 317-883-0567 |
 Priscilla Anne Rayback, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 895 S State Road 135, Target-1364, Greenwood, IN 46143 Phone: 317-883-5215 Fax: 317-883-5215 |
Tracy Eder Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 150 Marlin Dr, Greenwood, IN 46142 Phone: 317-885-3010 |
Maranatha Lee Hamilton, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3100 Meridian Parke Dr, Greenwood, IN 46142 Phone: 317-887-5757 |
Kevin Doss Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 655 Us 31, Greenwood, IN 46142 Phone: 317-881-1655 |
Nancy Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1290 N State Road 135, Greenwood, IN 46142 Phone: 317-865-0472 |
Dr. Myolin Kyaw, PHRAM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 Us Highway 31 S, Greenwood, IN 46143 Phone: 317-883-0567 |
Tiffany Smirat, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 882 S Sr 135, Greenwood, IN 46143 Phone: 317-851-1103 |
Manreet Uppal Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 2200 Independence Dr, Greenwood, IN 46143 Phone: 317-883-4145 |
Brian James Billingsly, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1133 N Emerson Ave, Greenwood, IN 46143 Phone: 317-885-0139 Fax: 317-885-0217 |
Dr. Briee Myleah Kulesa, PHARMD Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 1040 Sierra Dr Ste 1400, Greenwood, IN 46143 Phone: 317-528-7072 |
Dr. Stephen Douglas Fell, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 655 Us Highway 31 S, Greenwood, IN 46142 Phone: 317-881-1655 |
Ms. Joleen B. Sawyer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 720 S State Road 135, Greenwood, IN 46143 Phone: 317-888-6917 Fax: 317-888-6975 |
News Archive
Endo responds to FDA Complete Response letter for FORTESTA NDA
Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with low testosterone (Low T), also known as hypogonadism. The FDA's review period for Class 2 resubmissions typically is six months.
TAP and EPSRC Centre for Innovative Manufacturing in Regenerative Medicine continue collaboration
The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications is pleased to announce that its collaboration with leading translational research group, the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine at Loughborough University is to continue into a second five year phase. This follows the recent announcement by Prime Minister, Gordon Brown and Lord Mandelson, UK Secretary of State, Department for Business, Innovation and Skills of a £5.33 million grant to the centre.
Brain tumor care, treatment in spotlight
Patients, physicians, and those caring for loved ones with brain tumors will have an opportunity to attend two full days of programs hosted by health care professionals from the University of Rochester Medical Center.
Individualized vent-splitter may allow multiple COVID-19 patients to share single ventilator
As the pandemic swept across the nation in March, so did urgent questions about the virus' potential strain on the healthcare system.
CytRx granted patent for molecular chaperone amplifier drug candidate
CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that it has been granted a key patent by the European Patent Office that covers through 2024 the use of its orally available molecular chaperone amplifier drug candidate arimoclomol for the treatment or prevention of neurodegenerative diseases of the central nervous system (CNS).
› Verified 4 days ago
Occupational Therapists
Dentists
Counselors
Pharmacists
Clinical Social Workers
Psychologists
Marriage Counselors